November 21, 2025

CorMedix Inc. (CRMD): A Biotech Stock with a Promising 95% Upside Potential

Investors seeking growth opportunities in the biotechnology sector may find CorMedix Inc. (NASDAQ: CRMD) a compelling consideration. As a U.S.-based healthcare innovator, CorMedix focuses on developing..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Unpacking the 16.98% Potential Upside in the Diagnostics Sector

As the healthcare industry continues to evolve, Fulgent Genetics, Inc. (NASDAQ: FLGT) emerges as a noteworthy player in the diagnostics and research sector. Situated in the..

AMN Healthcare Services Inc (AMN): Investor Outlook Highlights 35% Potential Upside

AMN Healthcare Services Inc (NYSE: AMN), a key player in the medical care facilities industry, offers a wide array of technology-enabled healthcare workforce solutions. Based in..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: A Promising 25% Potential Upside with Robust Buy Ratings

Zenas BioPharma, Inc. (NASDAQ: ZBIO) is making waves in the biotechnology sector, drawing investor attention with its promising pipeline and significant market potential. With a market..

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Decoding the 180% Potential Upside

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) stands at a pivotal juncture within the biotechnology sector, capturing investor interest with its ambitious gene therapy programs aimed at tackling..

Anavex Life Sciences Corp. (AVXL) Investor Outlook: Exploring a 594% Potential Upside in the Biotechnology Sector

Anavex Life Sciences Corp. (NASDAQ: AVXL), a promising player in the biotechnology sector, is making waves with its ambitious focus on treating complex neurodegenerative and neuropsychiatric..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Exploring a Massive 255% Potential Upside

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is capturing investor attention with its promising therapeutic pipeline and a remarkable potential upside of 255.50%. As a biopharmaceutical company specializing..

AxoGen, Inc. (AXGN) Stock Analysis: A 23.5% Revenue Growth Propels Positive Investor Outlook

AxoGen, Inc. (NASDAQ: AXGN) is capturing the attention of investors in the healthcare sector, particularly within the medical devices industry, where its innovative approaches to peripheral..

Semler Scientific, Inc. (SMLR) Stock Analysis: A Healthcare Gem with 255% Potential Upside

Semler Scientific, Inc. (NASDAQ: SMLR) is capturing investor attention with its significant potential upside, as indicated by a robust analyst target price range. Despite recent challenges,..

Butterfly Network, Inc. (BFLY) Stock Analysis: Evaluating a Potential 68.82% Upside

Butterfly Network, Inc. (BFLY), a player in the healthcare sector specializing in medical devices, has been capturing investor attention with its innovative ultrasound imaging solutions. With..

CeriBell, Inc. (CBLL) Stock Analysis: Unveiling an 81% Potential Upside

CeriBell, Inc. (CBLL) is making waves in the healthcare sector with its innovative approach to addressing neurological conditions. As a medical technology company, CeriBell is pioneering..

Community Health Systems, Inc. (CYH) Stock Analysis: Navigating a 32.9% Potential Upside Amid Challenges

Community Health Systems, Inc. (CYH) operates at the heart of the U.S. healthcare sector, running a network of general acute care hospitals that provide a broad..

Valneva SE (VALN) Stock Analysis: Exploring a 36.62% Potential Upside in the Booming Biotech Sector

Valneva SE (VALN), a French biotechnology company, has rapidly emerged as a key player in the healthcare sector with its innovative approach to vaccines. Specializing in..

Altimmune, Inc. (ALT) Stock Analysis: Unveiling a 270% Potential Upside in Biotech

Altimmune, Inc. (NASDAQ: ALT) has captured the attention of investors with its compelling narrative and significant potential upside. As a clinical-stage biopharmaceutical company, Altimmune is primarily..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: High Growth Potential with a 96% Upside

ArriVent BioPharma, Inc. (NASDAQ: AVBP) stands as a promising player in the biotechnology sector, catching the attention of investors with its high-growth potential and a substantial..

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Exploring 33.73% Potential Upside in Biotech

Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company, is making waves in the biotechnology industry with a promising pipeline targeting chronic Hepatitis B virus (HBV)...

Immatics N.V. (IMTX) Stock Analysis: A Biotech Powerhouse with 75% Upside Potential

Immatics N.V. (NASDAQ: IMTX), a promising player in the biotechnology sector, has captured the attention of investors with its innovative approach to cancer treatment. With a..

Cullinan Therapeutics, Inc. (CGEM) Investor Outlook: Biotechnology Innovator with a 199% Potential Upside

Cullinan Therapeutics, Inc. (CGEM) is capturing investor attention with its promising potential upside of 199.44%, as suggested by the average target price set by analysts. As..

STAAR Surgical Company (STAA) Stock Analysis: Navigating Growth with a 90.17 Forward P/E

STAAR Surgical Company (NASDAQ: STAA), a key player in the medical instruments and supplies industry, is an intriguing prospect for investors, particularly due to its focus..

REGENXBIO Inc. (RGNX) Stock Analysis: Unpacking the 171.81% Upside Potential

Investors seeking opportunities in the biotechnology space may want to keep an eye on REGENXBIO Inc. (NASDAQ: RGNX), a company that is making waves with its..

Search

Funds

November 21, 2025

Search

Funds

November 21, 2025

FTSE 100

Funds